Osteosarcoma Follow-Up Recommendations
Check out both table-sets for Follow-up treatment
You may also download this table in a Word Document Format, print it out and give it to your primary care physician to keep a checklist of all screenings and tests that you have completed and still need to complete.
| Time off treatment | History and physical exam | Complete blood count, liver and kidney studies 1 | Chest X-ray | Chest CT scan | MRI or CT of primary site | X-ray of primary site | Bone Scan |
|---|---|---|---|---|---|---|---|
| End of treatment | X | X | X | X | X | X | |
| 3 months | X | X | X | ||||
| 6 months | X | X | X | X | |||
| 9 months | X | X | X | ||||
| 1 year | X | X | X | X | X | ||
| 1 ½ years | X | X | X | X | |||
| 2years | X | X | X | X | |||
| 2 ½ years | X | X | X | X | |||
| 3 years | X | X | X | X | |||
| 4 years | X | X | X | ||||
| 5 years | X | X | X | X | |||
| 6 years | X | X | X | ||||
| 7 years | X | X | X | ||||
| 8 years | X | X | X | ||||
| 9 years | X | X | X | ||||
| 10 years | X | X | X | ||||
| Yearly | X |
| Time off treatment | Echocardiogram and EKG | Audiogram | Hormone evaluation 2 | Surgical and functional evaluation | Fasting Lipid Profile 3 | Bone Density 4 |
|---|---|---|---|---|---|---|
| End of treatment | X | |||||
| 3 months | X | X | ||||
| 6 months | ||||||
| 9 months | ||||||
| 1 year | X | X | X 3 | X 4 | ||
| 1 ½ years | ||||||
| 2years | ||||||
| 2 ½ years | X | X | X | |||
| 3years | ||||||
| 4 years | ||||||
| 5 years | X | X | X | X 3 | X 4 | |
| 6 years | ||||||
| 7 years | ||||||
| 8 years | ||||||
| 9 years | ||||||
| 10 years | X 5 | X 6 | ||||
| Yearly |
1 CBC with differential and platelet count; AST, total bilirubin, creatinine, urinalysis, creatinine clearance, magnesium, calcium, phosphorus, BUN, electrolytes, alkaline phosphatase, albumin, bicarbonate-follow-up is required more often and for a longer period if abnormalities are detected.
2 Follicle-stimulating hormone, luteinizing hormone, estradiol/or testosterone (when > 15 years old).
3 Baseline at entry into long-term follow-up, then as per United States Preventive Task Force Recommendations.
4 Baseline at age 18, and repeated as clinically indicated.
5 Periodic evaluation is required in cases of detected abnormalities, or per recommendation of a cardiologist. The COG recommends EKG and Echocardiogram every two years for patients with this amount of anthracycline exposure.
6 Then regularly per recommendations of your orthopedic surgeon.
Osteosarcoma Online > Information for Patients > After Treatment > Osteosarcoma Follow-Up Recommendations
Site Design: Caroline Courtney